NISSEN BIOTECH ApS: Financial statements 2017
CVR: 32085245
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NISSEN BIOTECH ApS (CVR 32085245) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -6,047 and a net result of DKK 817 compared with DKK -45,298 the year before. Equity in the 2017 report amounted to DKK 58,103. The solvency ratio was 54.3%.
- Gross Profit
- DKK -6,047
- Profit/Loss
- DKK 817
- Equity
- DKK 58,103
- Total Assets
- DKK 107,087
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -6 t. | 817 | 58 t. | - |
| 2016 | - | -18 t. | -45 t. | 57 t. | - |
| 2015 | - | 12 t. | -29 t. | 103 t. | - |
| 2014 | - | 5 t. | -92 t. | 131 t. | - |
| 2013 | - | 12 t. | 96 t. | 223 t. | - |
Official annual report
Keep an eye on NISSEN BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NISSEN BIOTECH ApS has published its annual report for 2016. Gross profit came to DKK -17,597, and the net result was DKK -45,298.
About NISSEN BIOTECH ApS
NISSEN BIOTECH ApS was a Danish company of the type Anpartsselskab based in Risskov, founded in 2009. The company has been dissolved on 30 August 2021. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK 691 and a net result of DKK 21,064 compared with DKK -6,957 the year before. Equity in the 2019 report amounted to DKK 72,210.